Sort
82,697 grants matching “vaccine development”
Defending Against Systemic Mycoses
$761,801George S. Deepe · University Of Cincinnati · P01 · FY2008 · AI
Immune Reconstitution
$761,783Ronald E. Gress · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Multivalent Toxoid Vaccine for Prevention of S. aureus Invasive Diseases
$761,776M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2019 · AI
Research Project 1: Vaccine for Rapid Response to Filovirus Outbreak
$761,773Stefan L Hamm · University Of Texas Med Br Galveston · U19 · FY2023 · AI
PrEP and protective immune responses against HIV-1
$761,717Jared Baeten · University Of Washington · R01 · FY2012 · AI
Bifidobacterium infantis supplementation in early life to improve immunity in infants exposed to HIV: a randomized, placebo-controlled, double-blind trial
$761,676Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2025 · HD
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention
$761,618David Andrew Largaespada · University Of Minnesota · UG3 · FY2020 · CA
Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention
$761,618David Andrew Largaespada · University Of Minnesota · UG3 · FY2019 · CA
MECHANISMS REGULATING AIRWAY EOSINOPHILIC INFLAMMATION
$761,606University Of Texas Medical Br Galveston · P01 · FY2000 · AI
Multivalent nanocluster universal influenza vaccine given by microneedle patch
$761,509Baozhong Wang · Georgia State University · R01 · FY2021 · AI
Project 1: COVID-19 prevalence, transmission, and protection in extended first responder cohorts
$761,461Eugene M. Oltz · Ohio State University · U54 · FY2020 · CA
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$761,409Evan Alexander Scott · Northwestern University · R01 · FY2022 · AI
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$761,409Evan Alexander Scott · Northwestern University · R01 · FY2021 · AI
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
$761,361Peter G Szilagyi · University Of California Los Angeles · R01 · FY2020 · AI
Supramolecular pediatric HIV vaccine design
$761,359Joel H Collier · Duke University · R01 · FY2022 · AI
Administrative Core
$761,330James W. Curran · Emory University · P30 · FY2014 · AI
Intestinal Disease-enterocyte toxin interaction
$761,309Wayne Lencer · Boston Children'S Hospital · R37 · FY2011 · DK
The NEPRC SPF Rhesus Macaque Breeding Colony
$761,303R. Paul Johnson · Harvard Medical School · U42 · FY2013 · OD
Effects of a Novel, Scalable, and Sustainable Patient Portal Intervention on Diabetes-Related Outcomes: A Pragmatic Randomized Controlled Trial
$761,289William Martinez · Vanderbilt University Medical Center · R01 · FY2022 · DK
Urban Water Systems, Enteric Pathogen Distribution & Gut Microbiome Development in Children: A Natural Experiment in Mozambique
$761,233Karen Levy · Emory University · R01 · FY2019 · AI
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$761,196Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2019 · AI
Integrative Omics of HepB Vaccine Response in Co-Infection with Parasites
$761,155Elias K Haddad · Drexel University · U19 · FY2021 · AI
Effect of host immunity stimulated by viral IL-10-deleted RhCMV vaccines on SIV rebound
$761,122Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2017 · AI
Developing a novel agonist of CD137 for cancer immunoprevention
$761,094Haval Shirwan · University Of Missouri-Columbia · UG3 · FY2025 · CA
Developing a novel agonist of CD137 for cancer immunoprevention
$761,094Haval Shirwan · University Of Missouri-Columbia · UG3 · FY2024 · CA